NysnoBio Awarded Michael J. Fox Foundation Grant to Advance Parkin Gene Therapy
17 juil. 2023 16h05 HE | NysnoBio LLC
- The funding will support NB001 Parkin gene replacement therapy IND-enabling studies- Initial indication in a substantial, genetically defined Parkinson’s population: Parkin-PD- Parkin-PD mutations...